カテゴリー： LP Information, 世界

世界のバセドウ病治療市場2025-2031

【英語タイトル】Global Graves Disease Treatment Market Growth 2025-2031
	・商品コード：LP63337NR3001 ・発行会社（調査会社）：LP Information ・発行日：2026年2月・ページ数：110 ・レポート言語：英語・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日）・調査対象地域：グローバル・産業分野：製薬

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥574,620	見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）	USD5,490 ⇒換算￥861,930	見積依頼/購入/質問フォーム
Corporate License（閲覧人数無制限）	USD7,320 ⇒換算￥1,149,240	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

❖ レポートの概要 ❖

世界のバセドウ病治療市場規模は、2025年のUS$ millionから2031年にはUS$ millionへと拡大すると予測されており、2025年から2031年にかけて年平均成長率（CAGR）%で成長すると見込まれています。

バセドウ病は、甲状腺ホルモンの過剰産生（甲状腺機能亢進症）を引き起こす免疫系疾患です。甲状腺機能亢進症を引き起こす疾患は数多くありますが、バセドウ病はその代表的な原因の一つです。甲状腺ホルモンは体内の多くのシステムに影響を与えるため、バセドウ病の徴候や症状は多岐にわたります。
2022年の世界の医薬品市場規模は1,4750億米ドルであり、今後6年間で年平均成長率（CAGR）5％で成長すると見込まれている。医薬品市場には、化学医薬品と生物学的製剤が含まれる。生物学的製剤の市場規模は、2022年に3,810億米ドルに達すると予想されている。これに対し、化学医薬品市場は、2018年の1,0050億米ドルから2022年には1,0940億米ドルに拡大すると推定されています。医薬品市場を牽引する要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に向けた民間および政府機関からの資金提供の増加、ならびに医薬品の研究開発（R&D）活動の活発化などが挙げられます。しかし、この業界は、厳格な規制、研究開発の高コスト、特許の満了といった課題にも直面している。企業は、市場での競争力を維持し、製品を必要とする患者に確実に届けるために、継続的なイノベーションを図り、これらの課題に適応していく必要がある。さらに、COVID-19のパンデミックは、ワクチン開発とサプライチェーン管理の重要性を浮き彫りにし、製薬企業が新たな公衆衛生のニーズに機敏かつ迅速に対応する必要性を一層強調している。

LP Information, Inc.（LPI）の最新調査レポート『グレーブス病治療市場予測』は、過去の売上実績を検証し、2024年の世界のグレーブス病治療薬総売上高を分析するとともに、2025年から2031年までの予測売上高について、地域および市場セクター別の包括的な分析を提供しています。本レポートでは、バセドウ病治療薬の売上高を地域、市場セクター、サブセクター別に分類し、世界のバセドウ病治療薬業界について、百万米ドル単位で詳細な分析を提供しています。

本インサイトレポートは、世界のグレーブス病治療市場の全体像を包括的に分析し、製品セグメンテーション、企業構成、収益、市場シェア、最新動向、およびM&A活動に関連する主要なトレンドを浮き彫りにしています。また、本レポートでは、グレーブス病治療の製品ポートフォリオと能力、市場参入戦略、市場での位置づけ、および地理的展開に焦点を当て、世界的なグレーブス病治療市場の急速な拡大の中で、主要グローバル企業が占める独自の立場をより深く理解できるよう、各社の戦略を分析しています。

本インサイトレポートは、グレーブス病治療の世界的な見通しを形作る主要な市場動向、推進要因、および影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を細分化することで、新興のビジネスチャンスを浮き彫りにします。数百件に及ぶボトムアップ型の定性的・定量的市場データに基づく透明性の高い方法論により、本調査の予測は、世界のグレーブス病治療市場の現状と将来の軌跡について、極めて精緻な見解を提供します。

本レポートでは、製品タイプ、用途、主要メーカー、および主要地域・国別に、グレーブス病治療市場の包括的な概要、市場シェア、成長機会を提示しています。

タイプ別セグメンテーション：
抗甲状腺薬
放射性ヨウ素療法

用途別セグメンテーション：
病院・薬局
小売薬局

また、本レポートでは地域別に市場を分類しています：
南北アメリカ
米国
カナダ
メキシコ
ブラジル
アジア太平洋地域（APAC）
中国
日本
韓国

東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国

以下に紹介する企業は、主要な専門家からの情報および各社の事業範囲、製品ポートフォリオ、市場浸透度を分析した上で選定されています。

Abbott
Merck & Co
Pfizer, Inc
AbbVie, Inc
Mylan N.V
Allergan, plc
Novartis AG
Apitope
Amgen INC.
Sun Pharmaceuticals Industries LTD
Immunovant Inc

The global Graves Disease Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Graves” disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism). Although a number of disorders may result in hyperthyroidism, Graves” disease is a common cause. Thyroid hormones affect many body systems, so signs and symptoms of Graves” disease can be wide ranging.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ‘ newest research report, the “Graves Disease Treatment Industry Forecast” looks at past sales and reviews total world Graves Disease Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Graves Disease Treatment sales for 2025 through 2031. With Graves Disease Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Graves Disease Treatment industry.

This Insight Report provides a comprehensive analysis of the global Graves Disease Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Graves Disease Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Graves Disease Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Graves Disease Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Graves Disease Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Graves Disease Treatment market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Anti-Thyroid Medication
Radioactive Iodine Therapy

Segmentation by Application:
Hospitals Pharmacies
Retail Pharmacies

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company’s coverage, product portfolio, its market penetration.

Abbott
Merck & Co
Pfizer, Inc
AbbVie, Inc
Mylan N.V
Allergan, plc
Novartis AG
Apitope
Amgen INC.
Sun Pharmaceuticals Industries LTD
Immunovant Inc

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Graves Disease Treatment Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Graves Disease Treatment by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Graves Disease Treatment by Country/Region, 2020, 2024 & 2031
2.2 Graves Disease Treatment Segment by Type
2.2.1 Anti-Thyroid Medication
2.2.2 Radioactive Iodine Therapy
2.3 Graves Disease Treatment Sales by Type
2.3.1 Global Graves Disease Treatment Sales Market Share by Type (2020-2025)
2.3.2 Global Graves Disease Treatment Revenue and Market Share by Type (2020-2025)
2.3.3 Global Graves Disease Treatment Sale Price by Type (2020-2025)
2.4 Graves Disease Treatment Segment by Application
2.4.1 Hospitals Pharmacies
2.4.2 Retail Pharmacies
2.5 Graves Disease Treatment Sales by Application
2.5.1 Global Graves Disease Treatment Sale Market Share by Application (2020-2025)
2.5.2 Global Graves Disease Treatment Revenue and Market Share by Application (2020-2025)
2.5.3 Global Graves Disease Treatment Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Graves Disease Treatment Breakdown Data by Company
3.1.1 Global Graves Disease Treatment Annual Sales by Company (2020-2025)
3.1.2 Global Graves Disease Treatment Sales Market Share by Company (2020-2025)
3.2 Global Graves Disease Treatment Annual Revenue by Company (2020-2025)
3.2.1 Global Graves Disease Treatment Revenue by Company (2020-2025)
3.2.2 Global Graves Disease Treatment Revenue Market Share by Company (2020-2025)
3.3 Global Graves Disease Treatment Sale Price by Company
3.4 Key Manufacturers Graves Disease Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Graves Disease Treatment Product Location Distribution
3.4.2 Players Graves Disease Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Graves Disease Treatment by Geographic Region
4.1 World Historic Graves Disease Treatment Market Size by Geographic Region (2020-2025)
4.1.1 Global Graves Disease Treatment Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Graves Disease Treatment Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Graves Disease Treatment Market Size by Country/Region (2020-2025)
4.2.1 Global Graves Disease Treatment Annual Sales by Country/Region (2020-2025)
4.2.2 Global Graves Disease Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Graves Disease Treatment Sales Growth
4.4 APAC Graves Disease Treatment Sales Growth
4.5 Europe Graves Disease Treatment Sales Growth
4.6 Middle East & Africa Graves Disease Treatment Sales Growth
5 Americas
5.1 Americas Graves Disease Treatment Sales by Country
5.1.1 Americas Graves Disease Treatment Sales by Country (2020-2025)
5.1.2 Americas Graves Disease Treatment Revenue by Country (2020-2025)
5.2 Americas Graves Disease Treatment Sales by Type (2020-2025)
5.3 Americas Graves Disease Treatment Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Graves Disease Treatment Sales by Region
6.1.1 APAC Graves Disease Treatment Sales by Region (2020-2025)
6.1.2 APAC Graves Disease Treatment Revenue by Region (2020-2025)
6.2 APAC Graves Disease Treatment Sales by Type (2020-2025)
6.3 APAC Graves Disease Treatment Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Graves Disease Treatment by Country
7.1.1 Europe Graves Disease Treatment Sales by Country (2020-2025)
7.1.2 Europe Graves Disease Treatment Revenue by Country (2020-2025)
7.2 Europe Graves Disease Treatment Sales by Type (2020-2025)
7.3 Europe Graves Disease Treatment Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Graves Disease Treatment by Country
8.1.1 Middle East & Africa Graves Disease Treatment Sales by Country (2020-2025)
8.1.2 Middle East & Africa Graves Disease Treatment Revenue by Country (2020-2025)
8.2 Middle East & Africa Graves Disease Treatment Sales by Type (2020-2025)
8.3 Middle East & Africa Graves Disease Treatment Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Graves Disease Treatment
10.3 Manufacturing Process Analysis of Graves Disease Treatment
10.4 Industry Chain Structure of Graves Disease Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Graves Disease Treatment Distributors
11.3 Graves Disease Treatment Customer
12 World Forecast Review for Graves Disease Treatment by Geographic Region
12.1 Global Graves Disease Treatment Market Size Forecast by Region
12.1.1 Global Graves Disease Treatment Forecast by Region (2026-2031)
12.1.2 Global Graves Disease Treatment Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Graves Disease Treatment Forecast by Type (2026-2031)
12.7 Global Graves Disease Treatment Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Graves Disease Treatment Product Portfolios and Specifications
13.1.3 Abbott Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Merck & Co
13.2.1 Merck & Co Company Information
13.2.2 Merck & Co Graves Disease Treatment Product Portfolios and Specifications
13.2.3 Merck & Co Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck & Co Main Business Overview
13.2.5 Merck & Co Latest Developments
13.3 Pfizer, Inc
13.3.1 Pfizer, Inc Company Information
13.3.2 Pfizer, Inc Graves Disease Treatment Product Portfolios and Specifications
13.3.3 Pfizer, Inc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Pfizer, Inc Main Business Overview
13.3.5 Pfizer, Inc Latest Developments
13.4 AbbVie, Inc
13.4.1 AbbVie, Inc Company Information
13.4.2 AbbVie, Inc Graves Disease Treatment Product Portfolios and Specifications
13.4.3 AbbVie, Inc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 AbbVie, Inc Main Business Overview
13.4.5 AbbVie, Inc Latest Developments
13.5 Mylan N.V
13.5.1 Mylan N.V Company Information
13.5.2 Mylan N.V Graves Disease Treatment Product Portfolios and Specifications
13.5.3 Mylan N.V Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Mylan N.V Main Business Overview
13.5.5 Mylan N.V Latest Developments
13.6 Allergan, plc
13.6.1 Allergan, plc Company Information
13.6.2 Allergan, plc Graves Disease Treatment Product Portfolios and Specifications
13.6.3 Allergan, plc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Allergan, plc Main Business Overview
13.6.5 Allergan, plc Latest Developments
13.7 Novartis AG
13.7.1 Novartis AG Company Information
13.7.2 Novartis AG Graves Disease Treatment Product Portfolios and Specifications
13.7.3 Novartis AG Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Novartis AG Main Business Overview
13.7.5 Novartis AG Latest Developments
13.8 Apitope
13.8.1 Apitope Company Information
13.8.2 Apitope Graves Disease Treatment Product Portfolios and Specifications
13.8.3 Apitope Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Apitope Main Business Overview
13.8.5 Apitope Latest Developments
13.9 Amgen INC.
13.9.1 Amgen INC. Company Information
13.9.2 Amgen INC. Graves Disease Treatment Product Portfolios and Specifications
13.9.3 Amgen INC. Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Amgen INC. Main Business Overview
13.9.5 Amgen INC. Latest Developments
13.10 Sun Pharmaceuticals Industries LTD
13.10.1 Sun Pharmaceuticals Industries LTD Company Information
13.10.2 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Product Portfolios and Specifications
13.10.3 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Sun Pharmaceuticals Industries LTD Main Business Overview
13.10.5 Sun Pharmaceuticals Industries LTD Latest Developments
13.11 Immunovant Inc
13.11.1 Immunovant Inc Company Information
13.11.2 Immunovant Inc Graves Disease Treatment Product Portfolios and Specifications
13.11.3 Immunovant Inc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Immunovant Inc Main Business Overview
13.11.5 Immunovant Inc Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Graves Disease Treatment Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Graves Disease Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Anti-Thyroid Medication
Table 4. Major Players of Radioactive Iodine Therapy
Table 5. Global Graves Disease Treatment Sales by Type (2020-2025) & (K Units)
Table 6. Global Graves Disease Treatment Sales Market Share by Type (2020-2025)
Table 7. Global Graves Disease Treatment Revenue by Type (2020-2025) & ($ million)
Table 8. Global Graves Disease Treatment Revenue Market Share by Type (2020-2025)
Table 9. Global Graves Disease Treatment Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Graves Disease Treatment Sale by Application (2020-2025) & (K Units)
Table 11. Global Graves Disease Treatment Sale Market Share by Application (2020-2025)
Table 12. Global Graves Disease Treatment Revenue by Application (2020-2025) & ($ million)
Table 13. Global Graves Disease Treatment Revenue Market Share by Application (2020-2025)
Table 14. Global Graves Disease Treatment Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Graves Disease Treatment Sales by Company (2020-2025) & (K Units)
Table 16. Global Graves Disease Treatment Sales Market Share by Company (2020-2025)
Table 17. Global Graves Disease Treatment Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Graves Disease Treatment Revenue Market Share by Company (2020-2025)
Table 19. Global Graves Disease Treatment Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Graves Disease Treatment Producing Area Distribution and Sales Area
Table 21. Players Graves Disease Treatment Products Offered
Table 22. Graves Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Graves Disease Treatment Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Graves Disease Treatment Sales Market Share Geographic Region (2020-2025)
Table 27. Global Graves Disease Treatment Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Graves Disease Treatment Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Graves Disease Treatment Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Graves Disease Treatment Sales Market Share by Country/Region (2020-2025)
Table 31. Global Graves Disease Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Graves Disease Treatment Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Graves Disease Treatment Sales by Country (2020-2025) & (K Units)
Table 34. Americas Graves Disease Treatment Sales Market Share by Country (2020-2025)
Table 35. Americas Graves Disease Treatment Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Graves Disease Treatment Sales by Type (2020-2025) & (K Units)
Table 37. Americas Graves Disease Treatment Sales by Application (2020-2025) & (K Units)
Table 38. APAC Graves Disease Treatment Sales by Region (2020-2025) & (K Units)
Table 39. APAC Graves Disease Treatment Sales Market Share by Region (2020-2025)
Table 40. APAC Graves Disease Treatment Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Graves Disease Treatment Sales by Type (2020-2025) & (K Units)
Table 42. APAC Graves Disease Treatment Sales by Application (2020-2025) & (K Units)
Table 43. Europe Graves Disease Treatment Sales by Country (2020-2025) & (K Units)
Table 44. Europe Graves Disease Treatment Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Graves Disease Treatment Sales by Type (2020-2025) & (K Units)
Table 46. Europe Graves Disease Treatment Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Graves Disease Treatment Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Graves Disease Treatment Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Graves Disease Treatment Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Graves Disease Treatment Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Graves Disease Treatment
Table 52. Key Market Challenges & Risks of Graves Disease Treatment
Table 53. Key Industry Trends of Graves Disease Treatment
Table 54. Graves Disease Treatment Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Graves Disease Treatment Distributors List
Table 57. Graves Disease Treatment Customer List
Table 58. Global Graves Disease Treatment Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Graves Disease Treatment Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Graves Disease Treatment Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Graves Disease Treatment Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Graves Disease Treatment Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Graves Disease Treatment Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Graves Disease Treatment Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Graves Disease Treatment Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Graves Disease Treatment Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Graves Disease Treatment Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Graves Disease Treatment Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Graves Disease Treatment Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Graves Disease Treatment Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Graves Disease Treatment Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Abbott Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 73. Abbott Graves Disease Treatment Product Portfolios and Specifications
Table 74. Abbott Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Abbott Main Business
Table 76. Abbott Latest Developments
Table 77. Merck & Co Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 78. Merck & Co Graves Disease Treatment Product Portfolios and Specifications
Table 79. Merck & Co Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Merck & Co Main Business
Table 81. Merck & Co Latest Developments
Table 82. Pfizer, Inc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 83. Pfizer, Inc Graves Disease Treatment Product Portfolios and Specifications
Table 84. Pfizer, Inc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Pfizer, Inc Main Business
Table 86. Pfizer, Inc Latest Developments
Table 87. AbbVie, Inc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 88. AbbVie, Inc Graves Disease Treatment Product Portfolios and Specifications
Table 89. AbbVie, Inc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. AbbVie, Inc Main Business
Table 91. AbbVie, Inc Latest Developments
Table 92. Mylan N.V Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 93. Mylan N.V Graves Disease Treatment Product Portfolios and Specifications
Table 94. Mylan N.V Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Mylan N.V Main Business
Table 96. Mylan N.V Latest Developments
Table 97. Allergan, plc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 98. Allergan, plc Graves Disease Treatment Product Portfolios and Specifications
Table 99. Allergan, plc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Allergan, plc Main Business
Table 101. Allergan, plc Latest Developments
Table 102. Novartis AG Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 103. Novartis AG Graves Disease Treatment Product Portfolios and Specifications
Table 104. Novartis AG Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Novartis AG Main Business
Table 106. Novartis AG Latest Developments
Table 107. Apitope Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 108. Apitope Graves Disease Treatment Product Portfolios and Specifications
Table 109. Apitope Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Apitope Main Business
Table 111. Apitope Latest Developments
Table 112. Amgen INC. Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 113. Amgen INC. Graves Disease Treatment Product Portfolios and Specifications
Table 114. Amgen INC. Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Amgen INC. Main Business
Table 116. Amgen INC. Latest Developments
Table 117. Sun Pharmaceuticals Industries LTD Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 118. Sun Pharmaceuticals Industries LTD Graves Disease Treatment Product Portfolios and Specifications
Table 119. Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Sun Pharmaceuticals Industries LTD Main Business
Table 121. Sun Pharmaceuticals Industries LTD Latest Developments
Table 122. Immunovant Inc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors
Table 123. Immunovant Inc Graves Disease Treatment Product Portfolios and Specifications
Table 124. Immunovant Inc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Immunovant Inc Main Business
Table 126. Immunovant Inc Latest Developments

★調査レポート[世界のバセドウ病治療市場2025-2031] (コード：LP63337NR3001)販売に関する免責事項を必ずご確認ください。

★調査レポート[世界のバセドウ病治療市場2025-2031]についてメールでお問い合わせ

世界の市場調査レポート

世界のバセドウ病治療市場2025-2031

市場調査レポート・産業資料総合販売サイト MarketReport.jp

市場調査レポート・産業資料 総合販売サイト MarketReport.jp

市場調査レポート・産業資料総合販売サイト MarketReport.jp